• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病患者大脑中的磷酸果糖激酶活性

Phosphofructokinase activity in the brain in Alzheimer's disease.

作者信息

Sims N R, Blass J P, Murphy C, Bowen D M, Neary D

出版信息

Ann Neurol. 1987 May;21(5):509-10. doi: 10.1002/ana.410210517.

DOI:10.1002/ana.410210517
PMID:2954507
Abstract

The activity of phosphofructokinase, a key regulatory enzyme of glycolysis, was determined in neurosurgical samples of neocortex obtained from 6 patients with primary degenerative dementia, including 4 with Alzheimer's disease. No consistent reductions were seen compared with samples from nondemented controls. These results contrast with the greatly reduced activity reported previously for postmortem brain specimens from patients with Alzheimer's disease.

摘要

磷酸果糖激酶是糖酵解的一种关键调节酶,对6例原发性退行性痴呆患者(包括4例阿尔茨海默病患者)的新皮质神经外科样本测定了该酶的活性。与非痴呆对照样本相比,未发现一致的活性降低情况。这些结果与先前报道的阿尔茨海默病患者死后脑标本活性大幅降低形成对比。

相似文献

1
Phosphofructokinase activity in the brain in Alzheimer's disease.阿尔茨海默病患者大脑中的磷酸果糖激酶活性
Ann Neurol. 1987 May;21(5):509-10. doi: 10.1002/ana.410210517.
2
Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.阿尔茨海默病:临床和病理亚组脑组织中的胆碱乙酰转移酶活性
Ann Neurol. 1983 Sep;14(3):284-93. doi: 10.1002/ana.410140306.
3
Muscle biopsy in Alzheimer's disease: morphological and biochemical findings.阿尔茨海默病中的肌肉活检:形态学和生化研究结果
Clin Neuropathol. 1991 Jul-Aug;10(4):171-6.
4
[Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].[尸检中的神经病理学研究,特别关注阿尔茨海默病的发现]
Ideggyogy Sz. 2006 May 20;59(5-6):164-77.
5
[Histopathological and clinical considerations of 2 sporadic new cases of Alzheimer's dementia].[2例散发性阿尔茨海默病性痴呆新病例的组织病理学与临床考量]
Trab Inst Cajal Invest Biol. 1971;63:139-68.
6
Phenylethanolamine N-methyltransferase activity is decreased in Alzheimer's disease brains.苯乙醇胺N-甲基转移酶活性在阿尔茨海默病大脑中降低。
Ann Neurol. 1987 Aug;22(2):278-80. doi: 10.1002/ana.410220216.
7
[BB creatine phosphokinase activity and content of the brain structures in senile dementia and Alzheimer's diseases].[老年痴呆症和阿尔茨海默病中脑结构的肌酸磷酸激酶活性及含量]
Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(9):1374-8.
8
Cortical Lewy bodies in Alzheimer's disease.阿尔茨海默病中的皮质路易小体。
Arch Pathol Lab Med. 1995 May;119(5):448-53.
9
Cerebral atrophy in Parkinson's disease with and without dementia: a comparison with Alzheimer's disease, dementia with Lewy bodies and controls.伴或不伴痴呆的帕金森病患者的脑萎缩:与阿尔茨海默病、路易体痴呆及对照组的比较
Brain. 2004 Apr;127(Pt 4):791-800. doi: 10.1093/brain/awh088. Epub 2004 Jan 28.
10
Reduced phospholipase D activity in brain tissue samples from Alzheimer's disease patients.阿尔茨海默病患者脑组织样本中磷脂酶D活性降低。
Ann Neurol. 1986 Aug;20(2):265-7. doi: 10.1002/ana.410200214.

引用本文的文献

1
Potential mechanisms to modify impaired glucose metabolism in neurodegenerative disorders.改善神经退行性疾病中葡萄糖代谢受损的潜在机制。
J Cereb Blood Flow Metab. 2023 Jan;43(1):26-43. doi: 10.1177/0271678X221135061. Epub 2022 Oct 24.
2
Beyond amyloid: Immune, cerebrovascular, and metabolic contributions to Alzheimer disease in people with Down syndrome.超越淀粉样蛋白:唐氏综合征患者阿尔茨海默病的免疫、脑血管和代谢因素。
Neuron. 2022 Jul 6;110(13):2063-2079. doi: 10.1016/j.neuron.2022.04.001. Epub 2022 Apr 25.
3
Glycolytic Metabolism, Brain Resilience, and Alzheimer's Disease.
糖酵解代谢、脑弹性与阿尔茨海默病
Front Neurosci. 2021 Apr 28;15:662242. doi: 10.3389/fnins.2021.662242. eCollection 2021.
4
Molecular Mechanisms and Genetics of Oxidative Stress in Alzheimer's Disease.阿尔茨海默病中氧化应激的分子机制与遗传学
J Alzheimers Dis. 2019;72(4):981-1017. doi: 10.3233/JAD-190863.
5
Bioenergetics breakdown in Alzheimer's disease: targets for new therapies.阿尔茨海默病中的生物能量代谢紊乱:新疗法的靶点
Int J Physiol Pathophysiol Pharmacol. 2011;3(2):133-9. Epub 2010 Jun 12.
6
Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.全身和大脑代谢功能障碍作为一种治疗阿尔茨海默病痴呆症的新范式。
Neurochem Res. 2007 Apr-May;32(4-5):555-67. doi: 10.1007/s11064-006-9125-8. Epub 2006 Aug 17.
7
Analyses of energy metabolism and mitochondrial genome in post-mortem brain from patients with Alzheimer's disease.
J Neurol. 1993 Jun;240(6):377-80. doi: 10.1007/BF00839971.
8
Cerebral excess release of neurotransmitter amino acids subsequent to reduced cerebral glucose metabolism in early-onset dementia of Alzheimer type.
J Neural Transm. 1989;75(3):227-32. doi: 10.1007/BF01258634.